CDLX Form 144: Insider to sell 8,493 restricted shares on 10/02/2025

Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) Form 144 notice shows an insider intends to sell 8,493 shares of common stock, with an aggregate market value of $19,286.75, on or about 10/02/2025 through Fidelity Brokerage Services LLC on NASDAQ. The shares were acquired on 10/01/2025 by restricted stock vesting as compensation. The filer also reported two prior sales in the past three months: 7,324 shares sold on 07/02/2025 for $13,055.76 and 26,048 shares sold on 08/15/2025 for $31,695.21. The filer certifies no undisclosed material adverse information is known.

Positive

• 8,493 shares acquired by restricted stock vesting, indicating compensation rather than open-market purchase
• Sale will be executed through Fidelity Brokerage Services LLC on the NASDAQ, a regulated venue

Negative

• Insider proposes sale of 8,493 shares with aggregate market value $19,286.75, increasing insider supply
• Two prior sales in last three months totaling 33,372 shares were reported, potentially increasing sell-side pressure

Insights

Insider Transactions Analyst

Insider plans to sell recently vested 8,493 shares on 10/02/2025.

The filing states the 8,493 shares were acquired on 10/01/2025 through restricted stock vesting and are to be sold for an aggregate market value of $19,286.75 via Fidelity Brokerage Services LLC on NASDAQ.

The Form 144 also discloses two earlier sales by the same person in the past three months: 7,324 shares on 07/02/2025 for $13,055.76 and 26,048 shares on 08/15/2025 for $31,695.21, which are reported in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8493	19286.75	53236901	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Vesting	Issuer			8493	10/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alexis R. Desieno 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	07/02/2025	7324	13055.76
Alexis R. Desieno 675 Ponce de Leon Ave. NE Suite 4100 Atlanta GA 30308	Common	08/15/2025	26048	31695.21

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Cardlytics (CDLX) disclose?

It discloses an intended sale of 8,493 common shares valued at $19,286.75 with an approximate sale date of 10/02/2025 via Fidelity Brokerage Services LLC on NASDAQ.

How were the 8,493 Cardlytics shares acquired?

The filing states the shares were acquired on 10/01/2025 through restricted stock vesting and the payment nature is listed as compensation.

Has the filer sold other Cardlytics shares recently?

Yes. The filer sold 7,324 shares on 07/02/2025 for $13,055.76 and 26,048 shares on 08/15/2025 for $31,695.21.

Who is the broker and where will the sale occur?

The broker is Fidelity Brokerage Services LLC and the sale is planned on the NASDAQ exchange.

Does the filer assert any undisclosed material information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.